Prevalence of Stroke-Associated Pneumonia and Its Predictors Among Hyperglycaemia Patients During Acute Ischemic Stroke.

Autor:	Elhefnawy M; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, MYS., Nazifah Sidek N; Clinical Research Centre, Hospital Sultanah Nur Zahirah, Terengganu, MYS., Maisharah Sheikh Ghadzi S; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, MYS., Ibrahim B; Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, MYS., Looi I; Clinical Research Centre, Hospital Seberang Jaya, Seberang Jaya, MYS., Abdul Aziz Z; Clinical Research Centre, Hospital Sultanah Nur Zahirah, Terengganu, MYS., Noor Harun S; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, MYS.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2024 Jan 19; Vol. 16 (1), pp. e52574. Date of Electronic Publication: 2024 Jan 19 (Print Publication: 2024).
DOI:	10.7759/cureus.52574
Abstrakt:	Background: Hyperglycaemia (HG) during an acute ischemic stroke (AIS) is not only associated with unfavourable functional outcomes but also associated with stroke-associated pneumonia (SAP). This study aimed to determine the prevalence of SAP among Malaysian patients with AIS and the predictors of SAP among patients with HG during AIS. Methods: This is a retrospective cross-sectional study that included patients with AIS admitted to Hospital Sultanah Nur Zahirah, Malaysia from 2017 to 2020. SAP was defined as infection with pneumonia during the first seven days after IS. HG was defined as a blood glucose level > 7.8 mmol/L within 72 h after admission. Patients with SAP were divided into two groups according to HG status. Multivariate logistic regression analysis was performed using SPSS software, version 22 (IBM Corp., Armonk, NY) to identify SAP predictors among patients with HG. Kaplan-Meier log-rank test was used to compare the survival rate from unfavourable functional outcomes between hyperglycaemic patients with and without SAP. Results: Among 412 patients with AIS, 69 (16.74%) had SAP. The prevalence of SAP among patients with HG and normoglycemia during AIS was 20.98%, and 10.65%, respectively. Age above 60 years, leucocytosis, and National Institute of Health Stroke Scale (NIHSS) > 14 on admission were independent predictors of SAP with aOR of 2.08 (95% CI;1.01-4.30), 2.83 (95% CI; 1.41-5.67), and 3.67 (95% CI; 1.53-8.80), respectively. No significant difference in unfavourable functional outcomes survival was found among patients with and without SAP ( p = 0.653). Conclusion: This study demonstrated the prevalence of SAP was higher among patients with HG compared to normoglycemia during AIS. The patient being old, leucocytosis and severe stroke upon admission predict the occurrence of SAP among patients with HG during AIS. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Elhefnawy et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu